查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493309

生医材料市场规模、份额、趋势分析报告：按产品、按应用、按地区、细分市场预测，2024-2030

Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10个工作天内

价格

生医材料市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球生医材料市场规模预计将达到4,887亿美元，预测期内复合年增长率为15.6%。

生物材料的应用是生物医学研究快速发展的领域。提高生物材料的生物活性、相容性和机械性能的最新进展为组织工程、免疫工程和药物传输系统的应用提供了新的机会。

聚合生医材料的生物相容性、低毒性和可再生使其成为受控和靶向药物输送中强大的药物输送剂，为市场成长提供了利润丰厚的机会。改良的药物传递方法的出现，例如 PEG 包覆的脂质体、生物聚合物包覆的脂质体和奈米材料药物递送，进一步扩大了生物聚合物在製药和医疗产业的前景。

生物材料的使用极大地帮助了心肺系统的再生。这些材料为种子细胞提供物理支持以及生理和化学线索，有助于组织再生过程。生医材料和奈米技术的整合也刺激受损心肌细胞的细胞外基质再生，取代传统的器官移植。

生医材料市场报告亮点

  • 由于天然和合成可降解聚合物的高可得性及其在手术缝合线和植入中的广泛应用，聚合物产品部门占据了最大的销售份额。
  • 天然产物作为开发新药的新型生物活性物质的来源而广受欢迎，导致该领域快速增长。
  • 慢性骨骼和肌肉骨骼疾病发生率的增加预计将极大地推动对整形外科应用生医材料的需求。
  • 可以使用基于聚合酵素链锁反应（PCR）或非PCR方法的现有生物医学设备来检测冠状病毒（即SARS-COV-2）的感染。
  • 改善硅胶乳房植入的表面改性以防止包膜挛缩是推动生医材料在整形外科领域以最快速度使用的因素之一。
  • 生物感测器是用来检测诸如组织、酵素和细胞器等微生物产生的生物分子和生物元素等分析物的分析装置。
  • 由于有透过举办活动和资助计划来促进生医材料利用的公共和私人机构，北美预计将在收益占有率方面占据市场主导地位。
  • 由于多家本地製造商（主要在中国）开发低成本生医材料产品，亚太地区预计将快速成长。
  • 市场主要企业包括Medtronic、赢创、帝斯曼、BASF、柏克莱先进生医材料、Covalon Technologies 和 Zimmer Biomet Holdings。
  • 这些公司正在采取多项策略性成长倡议，包括新产品开发、合作伙伴关係和地理扩张，以提高其在市场上的影响力。
  • 例如，2022 年 3 月，Medtronic宣布与 Vizient 合作，将 Touchurge Enterprise 加入 Vizient 的产品组合中。该平台是一个由人工智慧驱动的视讯管理和分析平台，让手术团队可以轻鬆存取程式文件和见解。

目录

第一章调查方法和范围

第二章生医材料市场：执行摘要

  • 市场概述
  • 段简介
  • 竞争格局概览

第三章生医材料市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 生医材料市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析

第四章生医材料市场：产品估算与趋势分析

  • 细分仪表板
  • 按产品分類的全球生医材料市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 金属
  • 自然的
  • 陶瓷製品
  • 聚合物

第五章生医材料市场：应用估算/趋势分析

  • 细分仪表板
  • 全球生医材料应用市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 心血管
  • 眼科
  • 整形外科
  • 创伤治疗
  • 组织工程
  • 整容手术
  • 神经
  • 其他的

第六章生医材料市场：区域业务分析

  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章生医材料市场：竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
  • Medtronic
  • Evonik Industries AG
  • Carpenter Technology Corporation
  • Berkeley Advanced Biomaterials
  • Invibio Ltd
  • Zimmer Biomet Holdings, Inc
  • BASF SE
  • Covalon Technologies Ltd
  • Stryker
  • Johnson & Johnson
  • Dentsply Sirona
  • CoorsTek Inc
  • Corbion
  • Regenity Biosciences
Product Code: GVR-2-68038-637-0

Biomaterials Market Growth & Trends:

The global biomaterials market size is expected to reach USD 488.70 billion by 2030, registering a CAGR of 15.6% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.

Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.

Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocytes' extracellular matrix, thus replacing the traditional organ transplantation procedures.

Biomaterials Market Report Highlights:

  • High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
  • Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
  • Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
  • The infection from coronavirus, that is, SARS-COV-2 can be detected using existing biomedical devices which are based on either Polymerase Chain Reaction (PCR) or Non-PCR methods
  • Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
  • Biosensor, is an analytical device that is used to detect analytes such as biomolecules or biological elements of species produced by micro-organisms, that is tissues, enzymes, and organelles
  • North America is expected to dominate the market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
  • Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
  • Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
  • Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
  • For instance, in March 2022, Medtronic announced a collaboration with Vizient to add Touch Surgery Enterprise to Vizient's portfolio, which is an AI-powered video management and analytical platform that provides surgical teams with simple access to procedural recordings and insights

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List Of Primary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Biomaterials Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Biomaterials Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising Demand As A Consequence Of Accidental Injuries & Chronic Conditions
      • 3.3.1.2. Advances In Biomaterials Technologies
      • 3.3.1.3. Expansion In The Usage Scope Of Biomaterials
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Expense Associated With The Development Of Biomaterials
      • 3.3.2.2. Problems Related To Biocompatibility Of Biomaterials
  • 3.4. Biomaterials Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTLE Analysis

Chapter 4. Biomaterials Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Biomaterials Market By Product Outlook
  • 4.3. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 4.3.1. Metallic
      • 4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.2. Natural
      • 4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.3. Ceramics
      • 4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.4. Polymers
      • 4.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Biomaterials Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Biomaterials Market By Application Outlook
  • 5.3. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.3.1. Cardiovascular
      • 5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.2. Sensors
      • 5.3.1.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.3. Stents
      • 5.3.1.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.4. Guidewires
      • 5.3.1.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.5. Implantable Cardiac Defibrillators
      • 5.3.1.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.6. Pacemakers
      • 5.3.1.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.7. Vascular Grafts
      • 5.3.1.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.8. Others
      • 5.3.1.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.2. Ophthalmology
      • 5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.2. Synthetic Corneas
      • 5.3.2.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.3. Intraocular Lens
      • 5.3.2.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.4. Contact Lens
      • 5.3.2.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.5. Ocular Tissue Replacement
      • 5.3.2.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.6. Others
      • 5.3.2.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.3. Dental
      • 5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.2. Tissue Regeneration Materials
      • 5.3.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.3. Dental Implants
      • 5.3.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.4. Bone Grafts & Substitutes
      • 5.3.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.5. Dental Membranes
      • 5.3.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.6. Others
      • 5.3.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.4. Orthopedic
      • 5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.2. Joint Replacement biomaterials
      • 5.3.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.3. Orthobiologics
      • 5.3.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.4. Bioresorbable Tissue Fixation Products
      • 5.3.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.5. Visco supplementation
      • 5.3.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.6. Spine Biomaterial
      • 5.3.4.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.7. Others
      • 5.3.4.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.5. Wound Healing
      • 5.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.2. Fracture Healing Device
      • 5.3.5.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.3. Adhesion Barrier
      • 5.3.5.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.4. Skin Substitutes
      • 5.3.5.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.5. Internal Tissue Sealant
      • 5.3.5.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.6. Surgical Hemostats
      • 5.3.5.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.7. Others
      • 5.3.5.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.6. Tissue Engineering
      • 5.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.7. Plastic Surgery
      • 5.3.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.2. Facial Wrinkle Treatment
      • 5.3.7.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.3. Soft Tissue Fillers
      • 5.3.7.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.4. Craniofacial Surgery
      • 5.3.7.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.5. Bioengineered Skins
      • 5.3.7.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.6. Peripheral Nerve Repair
      • 5.3.7.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.7. Acellular Dermal Matrices
      • 5.3.7.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.8. Others
      • 5.3.7.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.8. Neurology
      • 5.3.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.2. Neural Stem Cell Encapsulation
      • 5.3.8.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.3. Shunting Systems
      • 5.3.8.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.4. Hydrogel Scaffold For CNS Repair
      • 5.3.8.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.5. Cortical Neural Prosthetics
      • 5.3.8.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.6. Others
      • 5.3.8.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.9. Others
      • 5.3.9.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Biomaterials Market: Regional Business Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 6.4. North America
    • 6.4.1. North America Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.4. Spain
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.7. Australia
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.7.3. Mexico
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Mexico Biomaterials Market, 2018 - 2030 (USD Million)
    • 6.7.4. Argentina
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Biomaterials Market, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Biomaterials Market: Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2023
  • 7.4. Participant's Overview
    • 7.4.1. Medtronic
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Evonik Industries AG
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Carpenter Technology Corporation
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Berkeley Advanced Biomaterials
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Invibio Ltd
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Zimmer Biomet Holdings, Inc
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. BASF SE
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Covalon Technologies Ltd
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Stryker
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Johnson & Johnson
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Dentsply Sirona
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. CoorsTek Inc
      • 7.4.12.1. Overview
      • 7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Corbion
      • 7.4.13.1. Overview
      • 7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Regenity Biosciences
      • 7.4.14.1. Overview
      • 7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 North America Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 U.S. Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Canada Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 Canada Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 9 Europe Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 10 Europe Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Europe Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 12 UK Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 UK Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 Germany Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Germany Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 France Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 France Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 Italy Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Italy Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Spain Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Spain Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 22 Sweden Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Sweden Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Norway Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Norway Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Denmark Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Denmark Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 31 Japan Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Japan Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 China Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 China Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 India Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 India Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Australia Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Australia Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 South Korea Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 South Korea Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Thailand Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Thailand Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 Latin America Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 44 Latin America Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 45 Latin America Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 Brazil Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Brazil Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Mexico Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 49 Mexico Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Argentina Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Argentina Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 MEA Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 53 MEA Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 MEA Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 South Africa Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 South Africa Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 UAE Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 UAE Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Biomaterials Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews In North America
  • Fig. 5 Primary Interviews In Europe
  • Fig. 6 Primary Interviews In APAC
  • Fig. 7 Primary Interviews In Latin America
  • Fig. 8 Primary Interviews In MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling For Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Biomaterials Market: Market Outlook
  • Fig. 14 Biomaterials Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Biomaterials Market Driver Impact
  • Fig. 20 Biomaterials Market Restraint Impact
  • Fig. 21 Biomaterials Market Strategic Initiatives Analysis
  • Fig. 22 Biomaterials Market: Product Movement Analysis
  • Fig. 23 Biomaterials Market: Product Outlook And Key Takeaways
  • Fig. 24 Logistics & distribution Market Estimates And Forecast, 2018 - 2030
  • Fig. 25 Metallic Market Estimates And Forecast, 2018 - 2030
  • Fig. 26 Natural Market Estimates And Forecast, 2018 - 2030
  • Fig. 27 Ceramics Market Estimates And Forecast, 2018 - 2030
  • Fig. 28 Polymers Market Estimates And Forecast, 2018 - 2030
  • Fig. 29 Biomaterials Market: Application Movement Analysis
  • Fig. 30 Biomaterials Market: Application Outlook And Key Takeaways
  • Fig. 31 Cardiovascular Market Estimates And Forecasts, 2018 - 2030
  • Fig. 32 Ophthalmology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 33 Dental Market Estimates And Forecasts, 2018 - 2030
  • Fig. 34 Orthopedic Market Estimates And Forecasts, 2018 - 2030
  • Fig. 35 Wound Healing Market Estimates And Forecasts, 2018 - 2030
  • Fig. 36 Tissue Engineering Market Estimates And Forecasts, 2018 - 2030
  • Fig. 37 Plastic Surgery Market Estimates And Forecasts, 2018 - 2030
  • Fig. 38 Neurology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 39 Others Market Estimates And Forecasts, 2018 - 2030
  • Fig. 40 Global Biomaterials Market: Regional Movement Analysis
  • Fig. 41 Global Biomaterials Market: Regional Outlook And Key Takeaways
  • Fig. 42 Global Biomaterials Market Share And Leading Players
  • Fig. 43 North America Market Share And Leading Players
  • Fig. 44 Europe Market Share And Leading Players
  • Fig. 45 Asia Pacific Market Share And Leading Players
  • Fig. 46 Latin America Market Share And Leading Players
  • Fig. 47 Middle East & Africa Market Share And Leading Players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, By Country
  • Fig. 54 North America
  • Fig. 55 North America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. Market Estimates And Forecasts, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada Market Estimates And Forecasts, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe Market Estimates And Forecasts, 2018 - 2030
  • Fig. 62 UK
  • Fig. 63 UK Market Estimates And Forecasts, 2018 - 2030
  • Fig. 64 Germany
  • Fig. 65 Germany Market Estimates And Forecasts, 2018 - 2030
  • Fig. 66 France
  • Fig. 67 France Market Estimates And Forecasts, 2018 - 2030
  • Fig. 68 Italy
  • Fig. 69 Italy Market Estimates And Forecasts, 2018 - 2030
  • Fig. 70 Spain
  • Fig. 71 Spain Market Estimates And Forecasts, 2018 - 2030
  • Fig. 72 Denmark
  • Fig. 73 Denmark Market Estimates And Forecasts, 2018 - 2030
  • Fig. 74 Sweden
  • Fig. 75 Sweden Market Estimates And Forecasts, 2018 - 2030
  • Fig. 76 Norway
  • Fig. 77 Norway Market Estimates And Forecasts, 2018 - 2030
  • Fig. 78 Asia Pacific
  • Fig. 79 Asia Pacific Market Estimates And Forecasts, 2018 - 2030
  • Fig. 80 China
  • Fig. 81 China Market Estimates And Forecasts, 2018 - 2030
  • Fig. 82 Japan
  • Fig. 83 Japan Market Estimates And Forecasts, 2018 - 2030
  • Fig. 84 India
  • Fig. 85 India Market Estimates And Forecasts, 2018 - 2030
  • Fig. 86 Thailand
  • Fig. 87 Thailand Market Estimates And Forecasts, 2018 - 2030
  • Fig. 88 South Korea
  • Fig. 89 South Korea Market Estimates And Forecasts, 2018 - 2030
  • Fig. 90 Australia
  • Fig. 91 Australia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 92 Latin America
  • Fig. 93 Latin America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 94 Brazil
  • Fig. 95 Brazil Market Estimates And Forecasts, 2018 - 2030
  • Fig. 96 Mexico
  • Fig. 97 Mexico Market Estimates And Forecasts, 2018 - 2030
  • Fig. 98 Argentina
  • Fig. 99 Argentina Market Estimates And Forecasts, 2018 - 2030
  • Fig. 100 Middle East And Africa
  • Fig. 101 Middle East And Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 104 Saudi Arabia
  • Fig. 105 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 106 UAE
  • Fig. 107 UAE Market Estimates And Forecasts, 2018 - 2030
  • Fig. 108 Kuwait
  • Fig. 109 Kuwait Market Estimates And Forecasts, 2018 - 2030
  • Fig. 110 Market Share Of Key Market Players- Biomaterials Market